Travoprost Ophthalmic Solution
Product Images NDC 71335-2888

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic (NDC 71335-2888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352888 Extendedlabel)

Text panel listing inactive ingredients in Travoprost Ophthalmic Solution .04 mg/mL. Ingredients include polyoxyl 40 hydrogenated castor oil, boric acid, propylene glycol, sorbitol, zinc chloride, sodium hydroxide and/or hydrochloric acid for pH adjustment, and water for injection USP.*

FDA Label Image

Label (Lbl713352888)

Label for Travoprost Ophthalmic Solution, USP 0.04% (0.004%), a 2.5 mL ophthalmic solution. The label includes the NDC 71335-2888-1 and indicates the product is relabeled by Bryant Ranch Prepack and manufactured by Micro Labs Limited. Additional storage and usage instructions are also visible.*

FDA Label Image

Travoprost-figa.jpg (Travoprost Figa)

An instructional illustration labeled Fig. A depicting an ophthalmic solution bottle with its cap and a tear-off tamper-evident ring. The diagram points out these features on the bottle.*

FDA Label Image

Travoprost-figb.jpg (Travoprost Figb)

An instructional illustration labeled "Fig. B" showing a hand twisting the safety seal or cap of an ophthalmic solution bottle. The image depicts the process of opening or adjusting the bottle cap, indicating how to properly handle the ophthalmic solution bottle for Travoprost Ophthalmic Solution.*

FDA Label Image

Travoprost-figc.jpg (Travoprost Figc)

Instructional illustration showing a hand gripping a dropper bottle of Travoprost Ophthalmic Solution, with the other hand twisting the cap to open it as indicated by a curved arrow. The image is labeled Fig. C and depicts how to remove the cap for use.*

FDA Label Image

Travoprost-str.jpg (Travoprost Str)

Chemical structure diagram of the active ingredient Travoprost, showing its molecular framework with various functional groups and stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.